[Trichosporon beigelii infection in immunodeficient patients].
Pierard
G E
GE
Service de Dermatopathologie, CHU du Sart Tilman, Liège.
Pierard-Franchimont
C
C
Rurangirwa
A
A
Hermanns
G
G
Dokekias
A
A
de Beule
D
D
Fillet
G
G
D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use; D001393:Azoles / Q000627:therapeutic use; D003881:Dermatomycoses / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000150:complications*; D007654:Ketoconazole / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009894:Opportunistic Infections / Q000188:drug therapy / Q000209:etiology*; D014250:Trichosporon
D000935:Antifungal Agents; D001393:Azoles; C060571:saperconazole; D007654:Ketoconazole
Trichosporonose des immunodéprimés.